A microRNA-27a mimic sensitizes human oral squamous cell carcinoma HSC-4 cells to hyperthermia through downregulation of Hsp110 and Hsp90

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 334-340

  Kariya, Ayako ^a   Furusawa, Yukihiro ^a   Yunoki, Tatsuya ^a   Kondo, Takashi ^a   Tabuchi, Yoshiaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Human oral squamous cell carcinoma; Hyperthermia; MicroRNA; MiR 27a

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 90; MICRORNA; MICRORNA 27A; UNCLASSIFIED DRUG; MIRN27 MICRORNA, HUMAN; OLIGORIBONUCLEOTIDE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELLULAR DISTRIBUTION; DOWN REGULATION; GENETIC TRANSFECTION; HEAT TOLERANCE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADAPTATION; AGONISTS; ANTIBODY SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS; HEAT; METABOLISM; MOLECULAR MIMICRY; MOUTH MUCOSA; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTATION, PHYSIOLOGICAL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HOT TEMPERATURE; HSP110 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MICRORNAS; MOLECULAR MIMICRY; MOUTH MUCOSA; OLIGORIBONUCLEOTIDES; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 84902653122     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1758     Document Type: Article

References (34)

1. Hildebrandt B, Wust P, Ahlers O, et al: The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43: 33-56, 2002. (Pubitemid 34722786)
2. Vos MJ, Hageman J, Carra S and Kampinga HH: Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 47: 7001-7011, 2008. (Pubitemid 351956349)
3. Minton KW, Karmin P, Hahn GM and Minton AP: Nonspecific stabilization of stress-susceptible proteins by stress-resistant proteins: a model for the biological role of heat shock proteins. Proc Natl Acad Sci USA 79: 7107-7111, 1982.
4. Lanneau D, Brunet M, Frisan E, Solary E, Fontenay M and Garrido C: Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 12: 743-761, 2008. (Pubitemid 351718062)
5. Ciocca DR and Calderwood SK: Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103, 2005. (Pubitemid 40942470)
6. Calderwood SK, Khaleque MA, Sawyer DB and Ciocca DR: Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31: 164-172, 2006. (Pubitemid 43361923)
7. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
8. Meltzer PS: Cancer genomics: small RNAs with big impacts. Nature 435: 745-746, 2005.
9. Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610, 2010.
10. Moss EG: MicroRNAs: hidden in the genome. Curr Biol 12: R138-R140, 2002.
11. Wang J and Cui Q: Specific roles of microRNAs in their interactions with environmental factors. J Nucleic Acids 2012: 978384, 2012.
12. Niemoeller OM, Niyazi M, Corradini S, et al: MicroRNA expression profiles in human cancer cells after ionizing radiation. Radiat Oncol 6: 29, 2011.
13. Wilmink GJ, Roth CL, Ibey BL, et al: Identification of microRNAs associated with hyperthermia-induced cellular stress response. Cell Stress Chaperones 15: 1027-1038, 2010.
14. Gwak HS, Kim TH, Jo GH, et al: Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One 7: e47449, 2012.
15. Chistiakov DA and Chekhonin VP: Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential. Eur J Pharmacol 684: 8-18, 2012.
16. Tabuchi Y, Wada S, Furusawa Y, Ohtsuka K and Kondo T: Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells. Int J Mol Med 29: 380-386, 2012.
17. Kariya A, Tabuchi Y, Yunoki T and Kondo T: Identification of common gene networks responsive to mild hyperthermia in human cancer cells. Int J Mol Med 32: 195-202, 2013.
18. Tabuchi Y, Furusawa Y, Kariya A, Wada S, Ohtsuka K and Kondo T: Common gene expression patterns responsive to mild temperature hyperthermia in normal human fibroblastic cells. Int J Hyperthermia 29: 38-50, 2013.
19. Hosaka S, Nakatsura T, Tsukamoto H, Hatayama T, Baba H and Nishimura Y: Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo. Cancer Sci 97: 623-632, 2006. (Pubitemid 44056611)
20. Xu W and Neckers L: Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clin Cancer Res 13: 1625-1629, 2007. (Pubitemid 46952925)
21. Plaisance-Bonstaff K and Renne R: Viral miRNAs. Methods Mol Biol 721: 43-66, 2011.
22. Naito Y and Bono H: GGRNA: an ultrafast, transcript-oriented search engine for genes and transcripts. Nucleic Acids Res 40: W592-W596, 2012.
23. Cho WS: OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60, 2007.
24. Kong YW, Ferland-McCollough D, Jackson TJ and Bushell M: MicroRNAs in cancer management. Lancet Oncol 13: e249-e258, 2012.
25. Guo J, Miao Y, Xiao B, et al: Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657, 2009.
26. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005. (Pubitemid 40094598)
27. Ott CE, Grünhagen J, Jäger M, et al: MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3′ UTR and coding-sequence binding sites. PLoS One 6: e16250, 2011.
28. Oh HJ, Chen X and Subjeck JR: Hsp110 protects heat-denatured proteins and confers cellular thermoresistance. J Biol Chem 272: 31636-31640, 1997. (Pubitemid 28013309)
29. Oh HJ, Easton D, Murawski M, Kaneko Y and Subjeck JR: The chaperoning activity of hsp110. Identification of functional domains by use of targeted deletions. J Biol Chem 274: 15712-15718, 1999.
30. Dorard C, de Thonel A, Collura A, et al: Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis. Nat Med 17: 1283-1289, 2011.
31. Den RB and Lu B: Heat shock protein 90 inhibition: rationale and clinical potential. Ther Adv Med Oncol 4: 211-218, 2012.
32. Bagatell R and Whitesell L: Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther 3: 1021-1030, 2004. (Pubitemid 39199597)
33. Ito A, Saito H, Mitobe K, et al: Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle-mediated hyperthermia with low Curie temperature. Cancer Sci 100: 558-564, 2009.
34. Workman P, Burrows F, Neckers L and Rosen N: Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann NY Acad Sci 1113: 202-216, 2007. (Pubitemid 350015011)